Cannabis Oil for Cancer Pain: What Trials Show About Relief, Risks, and Cure Claims

Does cannabis oil relieve cancer pain or cure cancer? In randomized trials of 1,442 adults with advanced cancer, adding cannabinoids to opioids did not reduce pain more than placebo. No clinical trial has shown that cannabis oil cures cancer, and the American Society of Clinical Oncology advises against using it as a cancer treatment outside research. Cannabinoids can help chemotherapy nausea that standard drugs do not control.

Stories of people with terminal cancer turning to homemade cannabis oil have circulated widely for years, often claiming the oil eased unbearable pain or even made tumors disappear. These stories reflect something real: cancer pain can be severe, and many patients feel their suffering is not being fully addressed. As cannabis has become legal in more places, use among people with cancer has grown quickly, often ahead of the science. This article reviews what controlled studies show about cannabis and cannabinoids for cancer pain, nausea, and tumor growth, the risks involved, and the treatments with the strongest evidence for relieving cancer pain.

Why Do People With Cancer Turn to Cannabis?

Many are looking for relief that conventional care has not provided. A 2017 survey in Cancer by Steven Pergam and colleagues at a Seattle cancer center, in a state with legal cannabis, found that 24 percent of 926 patients had used cannabis in the past year and 21 percent in the past month. Most used it for physical symptoms such as pain and nausea, and many for sleep, mood, or stress. Three in four wanted information about cannabis from their cancer providers, yet most said they were not getting it. When doctors do not discuss it, patients often rely on dispensary staff, websites, and personal stories instead. Dispensary staff are not required to have medical training, and advice can vary widely from one store to the next, which leaves patients to sort through conflicting claims during an already stressful time.

Does Cannabis Relieve Cancer Pain?

The best trials say it does not add meaningful relief for most patients already on opioids. A 2020 systematic review and meta-analysis in BMJ Supportive & Palliative Care by Elaine Boland and colleagues pooled five randomized controlled trials with 1,442 adults with cancer pain, all rated at low risk of bias. Cannabinoids reduced average pain scores by only 0.21 points more than placebo on a 0-to-10 scale, a difference that was not statistically significant, and when only the larger phase 3 trials were analyzed the difference was essentially zero. Patients taking cannabinoids were more than twice as likely to report sleepiness and more likely to report dizziness. The authors concluded that adding cannabinoids to opioids did not reduce cancer pain in adults with advanced cancer.

What Did the Large Nabiximols Trials Show?

Nabiximols, sold as Sativex, is a mouth spray containing roughly equal amounts of THC and CBD and is approved in some countries for multiple sclerosis spasticity. It was the best-studied candidate for cancer pain. Two phase 3 randomized trials reported in the British Journal of Pain in 2017 by Marie Fallon and colleagues tested it in patients with advanced cancer whose pain remained moderate to severe despite optimized opioid treatment. Neither trial met its main goal of reducing pain scores more than placebo. Some quality-of-life measures favored the spray, and a subgroup of younger U.S. patients showed a benefit, but post hoc findings like these are not reliable on their own. These failures were a major reason guidelines stopped short of recommending cannabinoids for cancer pain.

Can Cannabis Help With Chemotherapy Nausea?

Yes, for some patients, which is where cannabinoids have their clearest role in cancer care. A 2015 Cochrane review by Lesley Smith and colleagues analyzed 23 randomized trials of cannabis-based medicines for chemotherapy-induced nausea and vomiting. Compared with placebo, people taking cannabinoids were more likely to report no vomiting at all, though the evidence was rated low quality, and side effects such as dizziness and a “high” feeling led some to stop. Importantly, the trials were run between 1975 and 1991 and did not compare cannabinoids with modern anti-nausea drugs such as ondansetron. Two prescription cannabinoids, dronabinol and nabilone, are FDA-approved for chemotherapy nausea, and dronabinol is also approved for appetite loss in AIDS.

What Do Cancer Experts Now Recommend?

The American Society of Clinical Oncology’s 2024 guideline in the Journal of Clinical Oncology, led by Ilana Braun, reviewed 13 systematic reviews and additional trials and found the certainty of evidence for most outcomes was low or very low. The panel noted that access to and use of cannabis by adults with cancer has outpaced the science. It recommended against using cannabis or cannabinoids as a treatment aimed at the cancer itself, except in clinical trials, and said they may improve hard-to-control chemotherapy nausea when added to standard anti-nausea medicines. Whether they help pain, appetite, sleep, or anxiety remains uncertain. The guideline also urged clinicians to discuss cannabis openly and without judgment.

Can Cannabis Oil Cure Cancer?

There is no clinical evidence that it does. Laboratory and animal studies show that some cannabinoids can slow cancer cell growth or trigger cell death in dishes and in mice, which has fueled claims online. The first human study of this idea, a 2006 pilot trial in the British Journal of Cancer by Manuel Guzmán and colleagues, delivered THC directly into the tumors of nine patients with recurrent glioblastoma. It was designed to test safety, had no comparison group, and the patients’ median survival was 24 weeks, typical of this aggressive cancer. Homemade concentrated oils, often called Rick Simpson Oil after the man who popularized them, have never been tested in a controlled trial. Patients who delay or abandon proven treatment in favor of cannabis oil risk letting a treatable cancer progress, a danger also seen with other unproven remedies such as juice cleanses.

What Are the Risks of Using Cannabis During Cancer Treatment?

Cannabis is not risk-free, especially for people who are already ill and taking several medicines. In the cancer pain trials, cannabinoids more than doubled the odds of sleepiness and raised the risk of dizziness, which can lead to falls. CBD and THC are processed by liver enzymes that also handle many cancer drugs, blood thinners, and seizure medicines, so they can raise or lower drug levels. Smoking or vaping cannabis can irritate the lungs, a particular concern for people with lung cancer or weakened immunity. Heavy, long-term use can trigger cannabinoid hyperemesis syndrome, a cycle of severe vomiting that can be mistaken for chemotherapy side effects.

There is also a question about immunotherapy. A 2019 study in The Oncologist by Tarek Taha and colleagues reviewed 140 Israeli patients with advanced cancers treated with the immunotherapy drug nivolumab. The tumor response rate was 37.5 percent among those not using cannabis and 15.9 percent among those using it, although cannabis use was not linked to differences in progression-free or overall survival. Because the study was retrospective and small, it cannot prove that cannabis reduces immunotherapy’s effect, but it is a reason for patients on immunotherapy to discuss cannabis with their oncologists.

What Works Best for Cancer Pain?

Most cancer pain can be controlled with established treatments. A 2017 overview of Cochrane reviews by Philip Wiffen and colleagues found that about 19 of 20 people with moderate or severe cancer pain who are given opioids and can tolerate them should have their pain reduced to mild or no pain within 14 days, although the overall quality of the evidence was low. Most people experience side effects, such as constipation and nausea, which can usually be managed, and about 1 to 2 in 10 find them intolerable and need a change in treatment. Other tools include anti-inflammatory drugs, nerve pain medicines, steroids, radiation for painful bone tumors, nerve blocks, and physical and psychological therapies.

Palliative care specialists focus on exactly this problem. Palliative care is not reserved for the end of life. It can begin at diagnosis alongside cancer treatment, and teams of doctors, nurses, and counselors work on pain, nausea, sleep, mood, and family support. People whose pain is not controlled should ask for a referral, because untreated pain is often a sign that the treatment plan needs adjusting rather than that nothing more can be done.

Which Non-Drug Approaches Help Cancer Pain?

Several have reasonable evidence and can be combined with medicines. A 2022 joint guideline from the Society for Integrative Oncology and ASCO, published in the Journal of Clinical Oncology by Jun Mao and colleagues, reviewed 227 studies. It recommended acupuncture for joint pain caused by aromatase inhibitor drugs used in breast cancer, said acupuncture, reflexology, or acupressure may be offered for general cancer pain or musculoskeletal pain, suggested hypnosis for pain during medical procedures, and supported massage for people with pain in palliative or hospice care. The panel found that evidence for other mind-body practices and for natural products, a category that includes many cannabis products sold to patients, was low or inconclusive. Physical therapy, heat, gentle movement, and counseling can also help many people cope with pain.

How Do Cannabis and Standard Treatments Compare for Cancer Symptoms?

Goal	Cannabis or cannabinoids	Best-supported options
Cancer pain	No added benefit over placebo in high-quality trials	Opioids, other pain medicines, radiation, nerve blocks, palliative care
Chemotherapy nausea	May help when standard drugs fail (ASCO)	Modern anti-nausea drug combinations
Appetite and weight	Uncertain in cancer	Nutrition support; some prescription medicines
Sleep and anxiety	Uncertain	Counseling, sleep strategies, appropriate medicines
Treating the cancer	Not recommended outside trials	Surgery, chemotherapy, radiation, immunotherapy, targeted drugs

Why Do Personal Stories About Cannabis Feel So Convincing?

Many patients sincerely report feeling better with cannabis, and those experiences deserve respect. Several factors can explain the gap between personal reports and trial results. Cannabis can relax people, help them sleep, and make pain feel less distressing even if pain intensity does not change. Expectation plays a large role in pain, which is why placebo groups in pain trials often improve too. Pain from cancer also rises and falls on its own and with other treatments, so improvement after starting cannabis may have other causes. And the dramatic stories that spread online are not a random sample; people who felt no benefit rarely share their experience. Controlled trials exist to sort out these effects.

What About CBD Products?

CBD, or cannabidiol, is the non-intoxicating compound sold in oils, gummies, and creams. The only FDA-approved CBD medicine, Epidiolex, is approved for certain rare seizure disorders, and its label warns about liver enzyme elevations and interactions with other medicines. There is little evidence that over-the-counter CBD products relieve cancer pain, and independent testing has repeatedly found that many products contain more or less CBD than their labels state, and some contain THC. For people in cancer treatment, the interaction risk is the main concern, because CBD can change how the body processes some chemotherapy drugs and blood thinners.

How Should Patients Talk to Their Cancer Team About Cannabis?

Openly. ASCO’s guideline encourages clinicians to ask about cannabis without judgment, and patients benefit from raising it themselves. Share which products you use, how you take them, and what symptoms you are trying to treat. Ask whether cannabis could interact with your cancer treatment, including immunotherapy, and whether there are better-tested options for your specific symptom. If pain is the main problem, ask for a palliative care referral. If nausea persists despite medicines, ask whether a prescription cannabinoid could be added. Pharmacists can check for interactions, which is especially useful for people taking several drugs.

Is Medical Cannabis Legal?

It depends on where you live. In the United States, cannabis remains illegal under federal law except for FDA-approved products, while most states allow medical use and many allow recreational use, creating a confusing patchwork. Federal reclassification of cannabis has been under review, which could ease research restrictions. Canada and several other countries permit medical cannabis nationally. Legal access does not mean a product is proven to work for a given condition, and state-legal products are not reviewed by the FDA for safety or accuracy of labeling.

Why Has Research on Cannabis and Cancer Been So Limited?

Several barriers have slowed good trials. In the United States, cannabis has long been a Schedule I controlled substance, which required researchers to obtain special licenses, and for decades federally approved research cannabis came from a single supplier, often with lower potency than products sold in state dispensaries. Products vary widely in their mix of THC, CBD, and other compounds, making it hard to compare studies. Many existing trials are small, short, or decades old. Pharmaceutical companies have limited incentive to fund large trials of a plant that cannot be patented. These limits explain why guidelines call for more research, and why patients and doctors are often working with uncertain evidence.

What Should Caregivers Know About Cannabis at Home?

Safety at home matters, especially with edibles. Cannabis gummies, chocolates, and baked goods look like ordinary snacks, and poison control centers have reported sharp increases in accidental cannabis poisonings in young children and pets since legalization. Store all products locked, in original labeled packaging, and out of reach. Effects from edibles can take one to two hours to begin and last for many hours, which can lead people to take more than intended. Anyone using cannabis should not drive or operate machinery, and caregivers should watch for confusion, falls, or excessive sleepiness in frail patients, particularly when cannabis is combined with opioids or sleep medicines.

What Questions Should I Ask Before Trying a Cannabis Product?

What symptom am I trying to treat, and is there a better-tested option for it? Could this product interact with my chemotherapy, immunotherapy, or other medicines? Has the product been tested by an independent laboratory for its THC and CBD content and for contaminants such as pesticides, molds, and heavy metals? What side effects should I watch for, and when should I stop? Does my cancer team know I am using it? Asking these questions helps people make informed choices and reduces the chance of harm, whichever decision they make.

Common Myths

“Cannabis oil cures cancer.” No clinical trial has shown this.

“Cannabis is a proven cancer painkiller.” High-quality trials found no added benefit over placebo for patients on opioids.

“Natural means no side effects.” Sleepiness, dizziness, and drug interactions are common.

“CBD is always safe because it does not cause a high.” CBD can affect the liver and interact with medicines.

“Opioids cannot control severe cancer pain.” Most people with severe cancer pain get substantial relief from carefully managed opioids.

Key Terms

THC: Delta-9-tetrahydrocannabinol, the main intoxicating compound in cannabis.

CBD: Cannabidiol, a non-intoxicating cannabis compound.

Nabiximols: A THC and CBD mouth spray sold as Sativex.

Dronabinol and nabilone: Prescription cannabinoids approved for chemotherapy nausea.

Palliative care: Specialized medical care focused on relieving symptoms and stress of serious illness.

The Bottom Line

Cannabis oil is widely promoted for cancer pain and even as a cure, but the evidence does not support either claim. High-quality trials in more than 1,400 adults with advanced cancer found no added pain relief from cannabinoids over placebo, along with more sleepiness and dizziness, and no clinical trial has shown that cannabis treats cancer. ASCO advises against cannabis as a cancer treatment outside research but notes it may help stubborn chemotherapy nausea. For cancer pain, carefully managed opioids and palliative care help most people, and anyone using cannabis should tell their cancer team.

Frequently Asked Questions

Does cannabis oil help cancer pain?

High-quality evidence says it adds little or nothing for most patients already taking opioids. A 2020 meta-analysis of five randomized trials with 1,442 adults found no significant difference in pain between cannabinoids and placebo, while cannabinoids caused more sleepiness and dizziness. Some individuals report feeling better, often through improved sleep or relaxation, but measured pain relief in trials was not greater than placebo.

Can cannabis oil cure cancer?

No clinical evidence shows that cannabis oil cures cancer. Cannabinoids can slow cancer cell growth in laboratory and animal studies, but the only small human study, involving nine glioblastoma patients, was a safety trial without a comparison group. ASCO recommends against using cannabis to treat cancer itself except in clinical trials. Delaying proven treatment for cannabis oil can allow cancer to progress.

Is cannabis approved for any cancer symptoms?

Yes. The prescription cannabinoids dronabinol and nabilone are FDA-approved for chemotherapy-induced nausea and vomiting, and dronabinol is also approved for appetite loss in AIDS. ASCO’s 2024 guideline says cannabinoids may help nausea that persists despite standard anti-nausea medicines. Evidence for pain, appetite, sleep, and anxiety in cancer is uncertain.

Can cannabis interfere with cancer treatment?

Possibly. THC and CBD are processed by liver enzymes that also handle many cancer drugs and blood thinners, so interactions can occur. A 2019 study of 140 patients on the immunotherapy drug nivolumab found a lower tumor response rate among cannabis users, though survival did not differ. Patients should tell their oncologist about any cannabis use.

What is the most effective treatment for cancer pain?

For moderate to severe cancer pain, opioids remain the main treatment. A Cochrane overview found about 19 of 20 people who can tolerate opioids reach mild or no pain within 14 days. Other options include anti-inflammatory and nerve pain medicines, radiation for painful bone tumors, nerve blocks, and palliative care teams that specialize in difficult pain.

References

1. Boland EG, Bennett MI, Allgar V, et al. Cannabinoids for adult cancer-related pain: systematic review and meta-analysis. BMJ Supportive & Palliative Care. 2020;10(1):14–24. PMID 31959586
2. Fallon MT, Albert Lux E, McQuade R, et al. Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies. British Journal of Pain. 2017;11(3):119–133. PMID 28785408
3. Braun IM, Bohlke K, Abrams DI, et al. Cannabis and cannabinoids in adults with cancer: ASCO guideline. Journal of Clinical Oncology. 2024;42(13):1575–1593. PMID 38478773
4. Smith LA, Azariah F, Lavender VT, et al. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database of Systematic Reviews. 2015;(11):CD009464. PMID 26561338
5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. British Journal of Cancer. 2006;95(2):197–203. PMID 16804518
6. Pergam SA, Woodfield MC, Lee CM, et al. Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer. 2017;123(22):4488–4497. PMID 28944449
7. Taha T, Meiri D, Talhamy S, et al. Cannabis impacts tumor response rate to nivolumab in patients with advanced malignancies. The Oncologist. 2019;24(4):549–554. PMID 30670598
8. Mao JJ, Ismaila N, Bao T, et al. Integrative medicine for pain management in oncology: Society for Integrative Oncology–ASCO guideline. Journal of Clinical Oncology. 2022;40(34):3998–4024. PMID 36122322
9. Wiffen PJ, Wee B, Derry S, et al. Opioids for cancer pain: an overview of Cochrane reviews. Cochrane Database of Systematic Reviews. 2017;7:CD012592. PMID 28683172

Last updated: October 10, 2026